FDA Chief Makary Defends Agency’s Rigorous Rare Disease Drug Review Process WASHINGTON – Food and Drug Administration Commissioner Robert Califf’s successor, Marty …
FDA
-
-
Grail’s Galleri Cancer Screening Test Shows Limited Benefit in Landmark Study, Stock Plummets Shares of Grail, the biotech firm pioneering multi-cancer early …
-
The line between consumer wellness technology and regulated medical devices has become increasingly blurred in recent years. From earbuds offering enhanced audio …
-
Every two minutes, someone in the US is diagnosed with cancer. But what if that diagnosis could be delivered with unprecedented speed …
-
CDC Grant Fuels Controversy Over Hepatitis B Vaccine Trial Linked to FDA Official WASHINGTON – The Centers for Disease Control and Prevention …
-
FDA Broadens Approval of Addyi for Women Experiencing Sexual Desire Issues After Menopause The Food and Drug Administration (FDA) has expanded the …
-
The Dawn of Proactive Alzheimer’s: From Blood Tests to Smart Homes, a New Era of Early Detection Every 65 seconds, someone in …
-
FDA Drug Approval Process Under Scrutiny: Leadership Intervention Raises Concerns Washington – A recent shift in the Food and Drug Administration’s (FDA) …
-
FDA Greenlights Wave of AI-Powered Medical Innovations, Transforming Patient Care The U.S. Food and Drug Administration (FDA) has recently authorized a significant …
-
Washington D.C. – In a move hailed by patient advocates and industry leaders, the Food and Drug Administration has appointed Dr. Richard …